BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 21053121)

  • 1. Interactions of amphipathic CPPs with model membranes.
    Deshayes S; Konate K; Aldrian G; Heitz F; Divita G
    Methods Mol Biol; 2011; 683():41-56. PubMed ID: 21053121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing membrane interactions of CPPs.
    Gräslund A; Mäler L
    Methods Mol Biol; 2011; 683():33-40. PubMed ID: 21053120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of amphipathic carrier peptides with membrane components in relation with their ability to deliver therapeutics.
    Deshayes S; Morris MC; Divita G; Heitz F
    J Pept Sci; 2006 Dec; 12(12):758-65. PubMed ID: 17131287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics of lipid interactions with cell-penetrating peptides.
    Sauder R; Seelig J; Ziegler A
    Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanism of internalization of the cell-penetrating carrier peptide Pep-1 through conformational analysis.
    Deshayes S; Heitz A; Morris MC; Charnet P; Divita G; Heitz F
    Biochemistry; 2004 Feb; 43(6):1449-57. PubMed ID: 14769021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1.
    Henriques ST; Costa J; Castanho MA
    FEBS Lett; 2005 Aug; 579(20):4498-502. PubMed ID: 16083883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast membrane association is a crucial factor in the peptide pep-1 translocation mechanism: a kinetic study followed by surface plasmon resonance.
    Henriques ST; Castanho MA; Pattenden LK; Aguilar MI
    Biopolymers; 2010; 94(3):314-22. PubMed ID: 20049920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools for predicting binding and insertion of CPPs into lipid bilayers.
    Almeida PF
    Methods Mol Biol; 2011; 683():81-98. PubMed ID: 21053124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary amphipathic cell-penetrating peptides: structural requirements and interactions with model membranes.
    Deshayes S; Plénat T; Aldrian-Herrada G; Divita G; Le Grimellec C; Heitz F
    Biochemistry; 2004 Jun; 43(24):7698-706. PubMed ID: 15196012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR studies of three-dimensional structure and positioning of CPPs in membrane model systems.
    Mäler L; Gräslund A
    Methods Mol Biol; 2011; 683():57-67. PubMed ID: 21053122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
    Henriques ST; Castanho MA
    J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion.
    Eiríksdóttir E; Konate K; Langel U; Divita G; Deshayes S
    Biochim Biophys Acta; 2010 Jun; 1798(6):1119-28. PubMed ID: 20214875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peptide carrier Pep-1 forms biologically efficient nanoparticle complexes.
    Muñoz-Morris MA; Heitz F; Divita G; Morris MC
    Biochem Biophys Res Commun; 2007 Apr; 355(4):877-82. PubMed ID: 17331466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices.
    Zhou NE; Mant CT; Hodges RS
    Pept Res; 1990; 3(1):8-20. PubMed ID: 2134049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake of Aib-containing amphipathic helix peptide.
    Wada S; Tsuda H; Okada T; Urata H
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
    Deshayes S; Morris M; Heitz F; Divita G
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane binding and structure of de novo designed alpha-helical cationic coiled-coil-forming peptides.
    Vagt T; Zschörnig O; Huster D; Koksch B
    Chemphyschem; 2006 Jun; 7(6):1361-71. PubMed ID: 16680794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.
    Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA
    FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.